Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stellapharm is a leading pharmaceutical manufacturer based in Vietnam, established in 2000 and formerly known as the STADA-VN Joint Venture. The company specializes in the development and production of high-quality generic medicines, with a strong focus on antiviral treatments for HIV, Hepatitis B, and Hepatitis C. Stellapharm operates advanced manufacturing facilities in Binh Duong that have earned prestigious certifications including EU-GMP, PMDA-GMP, and WHO-GMP. Their extensive product portfolio also covers therapeutic areas such as cardiovascular disease, diabetes, and gastrointestinal disorders. In addition to domestic supply, the company is a significant exporter and provides contract manufacturing services to global pharmaceutical firms. Stellapharm is recognized for its commitment to international quality standards and its role in improving access to affordable healthcare in emerging markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stellapharm.